Product platform • Early-stage R&D

BlueLight Bandage

A flexible, active wound dressing designed to deliver controlled 405 nm visible blue light to the wound surface. The goal is to reduce microbial burden without antibiotics, chemical antimicrobials, or UV radiation — while staying within practical safety constraints for heat, dose, and uniform illumination.

WavelengthCentered near 405 nm (visible spectrum)
MechanismPhotobiological excitation → ROS → microbial damage
Design priorityUniformity + thermal isolation + controlled exposure
Intended contextPost-op sites, minor wounds, outpatient recovery

What makes this different from a normal dressing

Conventional dressings primarily serve as barriers: they protect the wound from friction and contamination, but they do not actively inactivate microbes that may already be present or that accumulate over time. Some dressings incorporate chemical antimicrobials, but chemical exposure, allergies, and resistance dynamics can complicate prolonged or prophylactic use.

BlueLight Bandage is conceived as an active dressing: it performs a controlled function at the wound surface through a non-ionizing, visible-light mechanism. The key engineering problem is not simply “make it bright,” but to deliver a measured dose uniformly and safely.

Design constraints we treat as non-negotiable

  • Uniform illumination to avoid hot spots and localized over-exposure
  • Thermal management to keep the wound interface comfortable
  • Time caps and predictable dosing behavior
  • Biocompatible contact materials at the skin-facing surface

Mechanism of action (plain-language + technical)

Many bacteria contain naturally occurring chromophores (including porphyrin-like molecules). Visible blue light in the 405 nm band can excite these molecules. That excitation can generate reactive oxygen species (ROS), which can damage microbial cellular components.

The bandage concept aims to harness this effect locally at the wound surface, using controlled exposure parameters and a physical architecture that emphasizes dose uniformity.

Local photochemistry

ROS generation occurs where the light is delivered — at the wound interface.

Non-UV spectrum

Designed around non-ionizing visible light rather than ultraviolet radiation.

Practical engineering

Diffusion, spacing, and thermal barriers matter as much as wavelength.

Sustainability and waste reduction (reusable architecture)

Conventional wound dressings are typically single-use, creating recurring material waste at high volume. The BlueLight Bandage is being developed as a reusable outer system with cleanable components, designed to reduce the number of disposable bandages used across repeated dressing changes.

Conservative framing: depending on usage patterns and component durability, a single reusable system could potentially replace on the order of ~6,000 single-use disposable bandages over its operational life (upper-bound estimate).

Device architecture (layer-by-layer)

The BlueLight Bandage is designed as a flexible, multi-layer stack. Each layer exists to solve a specific constraint: comfort at the skin interface, uniform optical delivery, thermal isolation, and stable positioning. The exact materials can vary, but the functional roles remain consistent.

1) Skin-contact interface

Biocompatible layer intended to be soft, conformal, and comfortable on curved anatomy.

2) Optical diffuser

Spreads light evenly to prevent localized hot spots and deliver consistent irradiance.

3) Thermal barrier

Insulates the wound from heat generated by LEDs and electronics.

4) Light-emission layer

405 nm LED array designed for flexibility and predictable coverage.

5) Outer stabilizer

Wrap or shell that secures the bandage and protects the internal stack.

6) Control & limits

Session caps, preset modes, and clear user feedback to support safe use.

Want the numbers?

The Research & Evidence page summarizes the literature, explains dose concepts, and shows how we think about validation and controls.

Research & Evidence

Intended use cases (design intent)

BlueLight Bandage is being developed with post-operative wound care as a primary application, especially where infection risk is elevated. Secondary use cases include minor cuts and abrasions and certain superficial wound scenarios where localized antimicrobial support is beneficial.

Primary focus

Post-operative prophylaxis — a controlled light-based intervention aimed at reducing surface-level microbial load during early recovery.

Secondary exploration

Minor wounds, abrasions, and skin disruptions where a non-pharmacologic antimicrobial approach could complement standard cleaning and bandaging practices.

This site describes research and development concepts. It is not a treatment protocol and does not provide medical advice.